Press release

Honasa Consumer Ltd. announced the strategic acquisition of a 58% majority stake in Fluence Pharma, a science-backed nutraceuticals company known for its patented Cyclical Nutrition Therapy and dermatologist network. This acquisition marks Honasa's entry into the high-growth nutraceuticals category, specifically targeting "inside-out" beauty, under a newly formed subsidiary, Honasa Health. Fluence Pharma reported ~INR 40 Crore revenue and over 20% EBITDA margin in FY26, and Honasa aims to leverage Fluence's science with its own brand-building and digital distribution capabilities.